4-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to <12 Yrs

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(17 sites)

United States

Applied Research Center of Arkansas, Little Rock, Arkansas

Connecticut Children's Medical Center, Hartford, Connecticut

Waterway Research & Associates Corp., Miami, Florida

Valencia Medical and Research Center, Miami, Florida

Orlando Health, Inc.- APH Center for Digestive Health and Nutrition, Orlando, Florida

Florida Pharmaceutical Research and Associates, Inc., South Miami, Florida

OSF Saint Francis Medical Center, Peoria, Illinois

Mankato Clinic Children's Health Center, Mankato, Minnesota

Boys Town National Research Hospital, Boys Town, Nebraska

One Perkins Square, Akron, Ohio

Prisma Health Children's Hospital, Greenville, South Carolina

Maspons Pediatric Gastro, El Paso, Texas

Proactive El Paso, LLC, El Paso, Texas

Texas Digestive Specialists, Harlingen, Texas

Pioneer Research Solutions Inc, Sugar Land, Texas

Clinical Research Partners, LLC, Richmond, Virginia

University Physicians and Surgeons, Inc, Huntington, West Virginia